Delivery Order SPE2DB20D3104-SPE2DB25FV8N4
Award Date 6/26/25
Potential Completion Date 6/27/25
Potential Value $4.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Glimepiride 4 mg tablets, a diabetes medication, with a ceiling value of $2,043.05 and a completion date of July 2, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a larger...
- This is a $5,238.22 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a medication used to treat diabetes. The contract has an ultimate completion date of June 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Glimepiride 4 mg tablets, a diabetes medication, with a ceiling value of $1,711.76 and a completion date of June 18, 2025. This is a Firm Fixed Price Delivery Order contract, which is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the supply of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $1,756.55 and a performance period through June 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a key vendor for federal healthcare programs,...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,082.29, is a delivery order for 4568754426 GLIMEPIRIDE 4 MG TABLET 100S. It is a firm fixed price contract with a completion date of July 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,826.50 firm fixed-price delivery order contract is for the supply of GLIMEPIRIDE 4 MG TABLET 100S, a medication used for the treatment of diabetes. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $5,651.24, for the supply of GLIMEPIRIDE 4 MG TABLET 100S. The contract has an ultimate completion date of May 28, 2025 and was awarded on May 27, 2025. The contract is not set aside and is open to full and open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,153.02 Firm Fixed Price delivery order contract covers the supply of 4567721896 - GLIMEPIRIDE 4 MG TABLET 100S, with a performance period through March 28, 2025. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a medication used to treat diabetes. The contract has a ceiling value of $22,381.46 and is a firm fixed price contract with a completion date of June 24, 2025. The contract is not set aside for any specific business category....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, for the supply of GLIMEPIRIDE 4 MG TABLET 100S. The firm-fixed-price contract has a ceiling value of $7,264.63 and a completion date of September 5, 2024. There is no set-aside designation for this award. Amerisourcebergen has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of...